Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial

Category Primary study
JournalANNALS OF ONCOLOGY
Year 2021
This article has no abstract
Epistemonikos ID: e1117a1a53584a74d77fbe82c15c9fcdcda13ab7
First added on: Feb 13, 2025